Internal Medicine · Brooklyn, NY
NPI
1326032012
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1797 Pitkin Ave
Brooklyn, NY, 11212
Phone (718) 971-1944
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
268 services
Medicare patients, 2024
91
Average age 76
Drug cost, 2024
$2.1M
11,223 prescriptions
Company payments, 2025
$1,976
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rattanjit S Kohli was code 99214 (office e&m - established), 130 times for 75 patients. In total Rattanjit S Kohli billed 268 services in 17 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 130 | 75 | $72.26 | $9,394 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 34 | 34 | $21.76 | $740 |
| 99213 Office E&M - Established | Office | 24 | 22 | $73.14 | $1,755 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 18 | 18 | $19.14 | $344 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 17 | 15 | $28.47 | $484 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 12 | 12 | $187.05 | $2,245 |
By year: 2022 $75K for 1,041 services; 2023 $20K for 311 services; 2024 $17K for 268 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rattanjit S Kohli prescribed most often to Medicare patients was Rosuvastatin Calcium, with 935 prescriptions and refills. In total Rattanjit S Kohli wrote 11,223 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 935 | 2,673 | 252 | $13K |
| Amlodipine-Valsartan Amlodipine Besylate/Valsartan | 612 | 1,688 | 158 | $27K |
| Amlodipine Besylate Generic | 461 | 1,223 | 138 | $2,710 |
| Atorvastatin Calcium Generic | 349 | 977 | 105 | $3,867 |
| Metformin Hcl Generic | 279 | 761 | 79 | $1,842 |
| Gabapentin Generic | 259 | 678 | 71 | $3,347 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 255 | 476 | 65 | $14K |
| Omeprazole Generic | 248 | 676 | 75 | $4,251 |
| Metoprolol Succinate Generic | 233 | 625 | 67 | $3,249 |
| Tamsulosin Hcl Generic | 228 | 598 | 70 | $2,738 |
| Fluticasone Propionate Generic | 214 | 326 | 72 | $2,177 |
| Labetalol Hcl Generic | 211 | 582 | 55 | $8,014 |
| Simvastatin Generic | 206 | 533 | 52 | $1,619 |
| Amlodipine-Olmesartan Amlodipine Bes/Olmesartan Med | 192 | 516 | 53 | $10K |
| Nifedipine Er Nifedipine | 188 | 540 | 50 | $5,546 |
Brand drugs: 2,120 claims; generic drugs: 8,653 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rattanjit S Kohli $1,976 ($1,976 in general payments such as food, travel and fees) from 11 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $696.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 32 | $696 |
| Kowa Pharmaceuticals America, Inc. | 7 | $235 |
| Dexcom, Inc. DXCM | 5 | $209 |
| Amgen Inc. AMGN | 4 | $206 |
| CeQur Corporation | 1 | $177 |
| Novo Nordisk Inc NVO | 5 | $127 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $125 |
| Exact Sciences Corporation EXAS | 3 | $75.64 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $74.89 |
| Shield Therapeutics Inc STX.L | 1 | $26.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.